Heron Therapeutics, Inc. (FRA:AXD2)

Heron Therapeutics Revenue

Heron Therapeutics had revenue of $38.21M USD in the quarter ending September 30, 2025, with 16.47% growth. This brings the company's revenue in the last twelve months to $155.10M, up 12.60% year-over-year. In the year 2024, Heron Therapeutics had annual revenue of $182.93M, down -4.80%.

• Revenue (ttm): $155.10M
• Revenue Growth: +12.60%
• P/S Ratio: 1.37
• Revenue / Employee: $1.27M
• Employees: 122
• Market Cap: 181.39M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	182.93M	-9.22M	-4.80%
Dec 31, 2023	192.15M	29.60M	18.21%
Dec 31, 2022	162.55M	76.20M	88.25%
Dec 31, 2021	86.35M	-2.29M	-2.59%
Dec 31, 2020	88.64M	-57.33M	-39.28%
Dec 31, 2019	145.97M	68.49M	88.41%
Dec 31, 2018	77.47M	46.71M	151.81%
Dec 31, 2017	30.77M	29.49M	2,305.55%
Dec 31, 2016	1.28M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	646.00K	-655.00K	-50.35%
Dec 31, 2010	1.30M	40.00K	3.17%
Dec 31, 2009	1.26M	892.00K	241.73%
Dec 31, 2008	369.00K	-43.00K	-10.44%
Dec 31, 2007	412.00K	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	5.39M	-	-